{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20230803",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "74981",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214200Orig1s006ltr.pdf",
              "date": "20230804",
              "type": "Letter"
            },
            {
              "id": "74999",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214200s006lbl.pdf",
              "date": "20230804",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20230405",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73954",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214200Orig1s004ltr.pdf",
              "date": "20230406",
              "type": "Letter"
            },
            {
              "id": "73967",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214200s004lbl.pdf",
              "date": "20230410",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20250825",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83198",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/214200Orig1s007ltr.pdf",
              "date": "20250826",
              "type": "Letter"
            },
            {
              "id": "83213",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/214200s007lbl.pdf",
              "date": "20250827",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210212",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "66228",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/214200s000lbl.pdf",
              "date": "20210216",
              "type": "Label"
            },
            {
              "id": "66579",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/214200Orig1s000ltr.pdf",
              "date": "20210308",
              "type": "Letter"
            },
            {
              "id": "66773",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/214200Orig1s000TOC.html",
              "date": "20210312",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA214200",
      "sponsor_name": "PHARMACOSMOS",
      "openfda": {
        "application_number": [
          "NDA214200"
        ],
        "brand_name": [
          "COSELA"
        ],
        "generic_name": [
          "TRILACICLIB"
        ],
        "manufacturer_name": [
          "G1 Therapeutics, Inc.",
          "Pharmacosmos Therapeutics Inc."
        ],
        "product_ndc": [
          "73462-101",
          "73594-0101"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "TRILACICLIB DIHYDROCHLORIDE"
        ],
        "rxcui": [
          "2479705",
          "2479710"
        ],
        "spl_id": [
          "fd1c99c8-df20-4278-b963-603bb0c10715",
          "8b1ee2ee-7097-4ded-9755-ffac490337c1"
        ],
        "spl_set_id": [
          "4b06922c-498d-4871-a037-84a44e6a6b6c",
          "b3179c19-78f3-4bf1-b73e-7f7638522ab1"
        ],
        "package_ndc": [
          "73462-101-01",
          "73594-0101-1"
        ],
        "unii": [
          "4BX07W725T"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "COSELA",
          "active_ingredients": [
            {
              "name": "TRILACICLIB DIHYDROCHLORIDE",
              "strength": "EQ 300MG BASE/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}